Private equity
Click here to find out more
Advising The Rohatyn Group on investment in Optimapharm d.d.
22 May 2020
QUICK READ
by multiple authors
Coronavirus
Click here to find out more
What you need to know about the UK Government's new Future Fund 2.0
19 May 2020
IN-DEPTH ANALYSIS
by multiple authors
Coronavirus
Click here to find out more
Landmark Future Fund to open 20 May
19 May 2020
QUICK READ
by multiple authors
Environmental, planning & regulatory
Click here to find out more
Hope for compensation for Corona-related plant closures increases
15 May 2020
Synapse
Click here to find out more
NHS can procure drugs for use outside of their approved indications if it's cheaper, court says
4 May 2020
IN-DEPTH ANALYSIS
Life sciences & healthcare
Click here to find out more
Renowned Life Sciences specialist Alison Dennis joins Taylor Wessing
1 May 2020
by multiple authors
Coronavirus
Click here to find out more
What you need to know about the UK government's new Future Fund
27 April 2020
IN-DEPTH ANALYSIS
by multiple authors
Synapse
Click here to find out more
Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?
22 April 2020
IN-DEPTH ANALYSIS
Technology, media & communications
Click here to find out more
Taylor Wessing advises UK Government on establishment of new £500m 'Future Fund' to support start-up technology and life sciences companies
21 April 2020
by Angus Miln
Patents & innovation
Click here to find out more
COVID-19 and public compulsory licensing of drugs in Europe
17 April 2020
IN-DEPTH ANALYSIS
by multiple authors
Synapse
Click here to find out more
COVID-19 and life sciences M&A
16 April 2020
IN-DEPTH ANALYSIS
by multiple authors